Skip to content

Determination of risk factors for developing osteoporosis in COPD GOLD II patients. A case control study to identify possible risk factors for developing osteoporosis in COPD GOLD II patients.

Determination of risk factors for developing osteoporosis in COPD GOLD II patients. A case control study to identify possible risk factors for developing osteoporosis in COPD GOLD II patients. - Osteoporosis in GOLD II COPD patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31334
Enrollment
100
Registered
2007-09-12
Start date
2007-09-17
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone decalcification. AND chronic bronchitis emfysema Osteoporosis

Interventions

None listed

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >=40 COPD GOLD II patients Written permission (informed consent) Men and women

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

MeasureTime frame
Determination of possible risk factors for the developing of osteoporosis in COPD GOLD II patients. Bone mineral density (T-score and Z-score): osteoporosis vs no osteoporosis • BMI/VVMI • Emfysema/chronic bronchitis (HRCT scan and diffusion capacity) • Hyperinflation • Physical capacity • Nutritional status • Infectious parameters (CRP, ESR, leucocytes) • Use of medication

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)